Benefit of Ethanol Sclerotherapy of Endometriomas Before Ovarian Stimulation on Pregnancy Rates in IVF/ICSI

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-43
SponsorPoissy-Saint Germain Hospital

About this trial

Evaluation of progressive pregnancy rates (with an embryo with cardiac activity at 12 weeks), on a first attempt at IVF/ICSI (fresh and frozen embryo transfers) following the discovery of one or two endometrioma(s) of 30 to 80 mm, without a history of cystectomy, and comparison between the two groups: ethanol sclerotherapy and therapeutic abstention

Eligibility criteria

Qualifiers

Infertile women aged 18 to 43,

Presenting one or 2 endometriotic cysts of 30 mm to 80 mm long axis, confirmed by ultrasound and/or pelvic MRI and without signs of atypia,

With indication of IVF/ICSI, first IVF/ICSI after the discovery of endometriosis cyst(s),

Having given their consent.

Disqualifiers

A history of ovarian cystectomy,

A non-homogeneous cyst that cannot be punctured (risk of incomplete aspiration),

Complex adnexal image that cannot exclude an associated hematosalpinx (communicating hematosalpinx, tissue component),

A recent tubo-ovarian infection,

Trial design

Treatments tested in this trial

  • ethanol sclerotherapy

Treatment groups

174 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators